Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects

Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects

Abstract Background Dutch guidelines advise extended anticoagulant treatment with direct oral anticoagulants or vitamin K antagonists for patients with idiopathic venous thromboembolism (VTE) who do not have high bleeding risk. Objectives The aim of this study was to analyz...

Full description

Bibliographic Details
Main Authors: Lisa A. de Jong, Judith J. Gout-Zwart, Jelena Stevanovic, Harrie Rila, Mike Koops, Menno V. Huisman, Maarten J. Postma
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2018-07-01
Series:TH Open
Subjects:
cost-effectiveness
venous thrombosis
apixaban
lifelong treatment
non–vitamin k oral anticoagulants
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1672185

Internet

http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1672185

Similar Items